This study is in progress, not accepting new patients
A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3
Summary
- Eligibility
- for people ages 18-70 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Biogen
- ID
- NCT05160558
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- About 8 people participating
- Last Updated